DOUNAY, AMY BETH,MCALLISTER, LAURA ANN,PARIKH, VINOD D.,RONG, SUOBAO,VERHOEST, PATRICK ROBERT
申请号：
CA2819102
公开号：
CA2819102A1
申请日:
2011.11.17
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
Compounds of Formula I: (I) wherein X, Y, Z, R 1, R 2, R 3, R 4 are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive 5 deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammals, including humans.
